FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

TAKE

60.3
+0.1 (0.17%)
Updated 01:52 30/07 IST

TAKE Buy or Sell - FrontPage Forums

5 Users have submitted 5 trade ideas of Rs. 517,438 for TAKE
Disclaimer
100% Bullish
0% Bearish

TAKE Buy or Sell - Brokerage Reports

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
172
Consensus Potential
65.00%
See TAKE Share Price Targets >>

TAKE Ratings

Long term TAKE rating by FrontPage users
5/5 (2 Ratings)
Find answers to all your questions on live TAKE message board: Is TAKE buy or sell? Should I buy TAKE shares? Why are TAKE shares falling? Should I invest in TAKE stock?

  1. Home
  2. TAKE Forum

TAKE Share Price Discussion


Type
Buy
Instrument
TAKE
Entry Price
₹58.75
Price@Trade
₹58.75
Target Price
₹70
Stop Price
₹53
Valid Till
Aug 27, 2021 3:20 AM
Margin
₹5,875 approx for 100 Qty
Status
Active
Like
Reply
swap_vert
Trade
Like
Reply
Like
Reply

Type
Buy
Instrument
TAKE
Entry Price
₹61.1
Price@Trade
₹61
Target Price
₹68
Stop Price
₹58
Valid Till
Aug 20, 2021 3:20 AM
Margin
₹61,100 approx for 1000 Qty
Status
Exited
Exit Price
₹61.75
Net P&L
+₹650 (+1.06%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 20 4:55 AM

Update
Trade Entered
Entry Price
₹61.1

Update
Exited
Exit Price
₹61.75
Net P&L
+₹650 (+1.06%)

Type
Buy
Instrument
TAKE
Entry Price
₹66.5
Price@Trade
₹66.15
Target Price
₹80
Stop Price
₹62.5
Valid Till
Jul 15, 2022 3:20 AM
Margin
₹66,500 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹62.5
Net P&L
-₹4,000 (-6.02%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 16 3:35 AM

Update
Trade Entered
Entry Price
₹66.5
TrackerBot @trackerbot
Jul 20 3:07 AM

Update
Stoploss Hit
Exit Price
₹62.5
N
Reputation: 88 • Jul 5 3:14 AM
Like
Reply
M
Reputation: 248 • Jul 2 8:33 AM

Type
Buy
Instrument
TAKE
Entry Price
₹65.95
Price@Trade
₹65.95
Target Price
₹72
Stop Price
₹60
Valid Till
Aug 2, 2021 3:20 AM
Margin
₹16,487.5 approx for 250 Qty
Status
Exited
Exit Price
₹65.95
Net P&L
₹0 (0%)
Like
Reply (1)
swap_vert
Trade
See all replies
Mahendra @MAHENDRA63
Jul 16 5:07 AM

Update
Exited
Exit Price
₹65.95
Net P&L
₹0 (0%)
Like
Reply

Type
Buy
Instrument
TAKE
Entry Price
₹63.65
Price@Trade
₹63.65
Target Price
₹70
Stop Price
₹61
Valid Till
Jul 9, 2021 3:20 AM
Margin
₹6,365 approx for 100 Qty
Status
Exited
Exit Price
₹65.8
Net P&L
+₹215 (+3.38%)
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited
Exit Price
₹65.8
Net P&L
+₹215 (+3.38%)

Type
Sell
Instrument
TAKE
Entry Price
₹63.85
Price@Trade
₹63.75
Target Price
₹62
Stop Price
₹65
Valid Till
Jul 2, 2021 3:20 AM
Margin
₹6,385 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹65
Net P&L
-₹115 (-1.8%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 2 4:32 AM

Update
Trade Entered
Entry Price
₹63.85
TrackerBot @trackerbot
Jul 2 8:17 AM

Update
Stoploss Hit
Exit Price
₹65
S
Reputation: 0 • Jul 2 3:36 AM

Type
Buy
Instrument
TAKE
Entry Price
₹62.5
Price@Trade
₹63.15
Target Price
₹72
Stop Price
₹60
Valid Till
Jul 9, 2021 3:20 AM
Margin
₹156,250 approx for 2500 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
Suraj @Surajsk
Jul 6 2:52 AM

Update
Exited before entry
Price @ Update
₹66.35
Like
Reply
N
Reputation: 88 • Jul 1 7:04 AM
Like
Reply
N
Reputation: 15,707 • Jun 25 10:26 AM
Biggest gainers and losers: Deepak Spinners surges 20%, Dhunseri Tea drops 10%
Banking and metal stocks lifted the market.
The Economic Times
Like
Reply
Like
Reply
N
Reputation: 15,707 • Jun 25 5:16 AM
TAKE Solutions sheds 7% after posting Q4 loss
The pharmaceuticals company reported a net loss of Rs 68.13 crore in the March 2021 quarter. However, the loss has narrowed 60 per cent. The company reported a net loss of Rs 159.15 in the same quarter previous year. The counter shed 7 per cent to Rs 65.45 on Friday, but was trading at Rs 66.20 at 10.45 am. BSE Sensex was trading with mild cuts at 52,676.05 at the same time. The counter had settled at Rs 70.35 on Thursday.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jun 25 5:11 AM
TAKE Solutions sheds 7% as company posts loss in Q4
The pharmaceuticals company reported a net loss of Rs 68.13 crore in the March 2021 quarter. However, the loss has narrowed 60 per cent. The company reported a net loss of Rs 159.15 in the same quarter previous year. The counter shed 7 per cent to Rs 65.45 on Friday, but was trading at Rs 66.20 at 10.45 am. BSE Sensex was trading with mild cuts at 52,676.05 at the same time. The counter had settled at Rs 70.35 on Thursday.
The Economic Times
Like
Reply

Type
Buy
Instrument
TAKE
Entry Price
₹66
Price@Trade
₹66.25
Target Price
₹100
Stop Price
₹50
Valid Till
Jun 24, 2022 3:20 AM
Margin
₹6,600 approx for 100 Qty
Status
Exited
Exit Price
₹64
Net P&L
-₹200 (-3.03%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 25 3:07 AM

Update
Trade Entered
Entry Price
₹66

Update
Exited
Exit Price
₹64
Net P&L
-₹200 (-3.03%)
K
Reputation: 0 • Jun 24 6:26 AM

Type
Buy
Instrument
TAKE
Entry Price
₹71.5
Price@Trade
₹72.1
Target Price
₹76
Stop Price
₹69.8
Valid Till
Jun 24, 2021 3:20 AM
Margin
₹71,500 approx for 1000 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
Kakumar @kakumar
Jun 24 6:27 AM

Update
Exited before entry
Price @ Update
₹71.8
K
Reputation: 0 • Jun 24 6:04 AM

Type
Buy
Instrument
TAKE
Entry Price
₹73.2  ₹73
Price@Trade
₹73.4
Target Price
₹76
Stop Price
₹71
Valid Till
Jun 24, 2021 3:20 AM
Margin
₹73,000 approx for 1000 Qty
Status
Exited before entry
Like
Reply (2)
swap_vert
Trade
See all replies
Kakumar @kakumar
Jun 24 6:06 AM

Update
Entry Price Modified
Price @ Update
₹73.25
Original Entry Price
₹73.2
New Entry Price
73.0
Kakumar @kakumar
Jun 24 6:07 AM

Update
Exited before entry
Price @ Update
₹73.3
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • TAKE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,214.8
    Enterprise Value2,189.87
    Price to Earnings158.52
    Price to Book Value2.9
    Return on Capital Employed0.04
    Return on Equity0.02
    Face Value1
    Dividend Yield0.01
  • TAKE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    20-Aug-19Axis DirectBuy172
    15-Jul-19Axis DirectBuy143
    28-May-19Karvy Stock BrokingHold163
    11-Mar-19AUM CapitalBuy154
    18-Feb-19Axis DirectBuy146
    TAKE Brokerage Price Target
  • TAKE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 2959.6561.459.6560.2
    Jul 2861.2561.5558.259.4
    Jul 2762.262.8560.5561.15
    Jul 2663.964.161.9562.2
    Jul 2362.3565.261.2564.1
  • TAKE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹63.34
    30 Day Moving Average₹64.4
    50 Day Moving Average₹65.91
    100 Day Moving Average₹59.38
    200 Day Moving Average₹54.71
  • TAKE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2.4418.84-0.87
    Operating Profit-16.2-1.0714.14
    Profit Before Tax14.7418.51-0.2
    Net Income15.2518.35-0.17
  • TAKE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds762.45769.53-0.01
    Total Liabilities11.817.150.65
    Total Assets774.26776.68-0
  • TAKE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-24.02-56.57-0.58
    Cash from Investing Activity-48.01-23.291.06
    Cash from Financing Activity199.4981.221.46
    Net Cash Flow127.461.3692.72
  • TAKE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17Mar-16
    Return on Assets0.020.04NA
    Return on Equity0.020.04NA
    Return on Capital Employed0.040.05NA
  • TAKE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.91
    3 Year CAGR Growth in Operating Profit-12.25
    3 Year CAGR Growth in EBIDTA-0.14
    3 Year CAGR Growth in Net Income0.35
    3 Yr CAGR Growth - Diluted EPS0.11
  • TAKE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.92
    5 Year CAGR Growth in Operating Profit-3.78
    5 Year CAGR Growth in EBIDTA-0.57
    5 Year CAGR Growth in Net Income-0.58
    3 Yr CAGR Growth - Diluted EPS-0.66
  • TAKE - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 25 5:16 AM
    TAKE Solutions sheds 7% after posting Q4 loss
    The Economic Times
    NewsBot
    Jun 25 5:11 AM
    TAKE Solutions sheds 7% as company posts loss in Q4
    The Economic Times
    NewsBot
    Feb 18 4:23 AM
    NewsBot
    Jun 15, 2020 2:58 AM
    Take Solutions Consolidated March 2020 Net Sales at Rs 370.67 crore, down 30.58% Y-o-Y
    Moneycontrol
    NewsBot
    Mar 18, 2020 1:18 AM
    Stocks in the news: Avenue Supermarts, L&T, M&M, Fortis Healthcare
    Moneycontrol
    NewsBot
    Mar 17, 2020 2:08 AM
    Trade Setup for Wednesday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Feb 13, 2020 10:23 AM
    TAKE Solutions records consolidated Q3 profits at Rs 51.14 cr
    Moneycontrol
    NewsBot
    Aug 28, 2019 2:08 AM
    How a midsize Chennai IT firm became a Rs 2,000-crore clinical-research company
    Moneycontrol
    NewsBot
    Aug 8, 2019 10:33 AM
    Take Solutions Consolidated June 2019 Net Sales at Rs 582.74 crore, up 24.64% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 8, 2019 10:33 AM
    Take Solutions Standalone June 2019 Net Sales at Rs 0.48 crore, up 20.58% Y-o-Y
    moneycontrol.com
  • TAKE - Related Communities

    keyboard_arrow_down
    Tata Consultancy Services Ltd. NSE: T...
    Infosys Ltd. NSE: INFY | BSE: 500209 ...
    Wipro Ltd. NSE: WIPRO | BSE: 507685 |...
    HCL Technologies Ltd. NSE: HCLTECH | ...
    Tech Mahindra Ltd. NSE: TECHM | BSE: ...
    MindTree Ltd. NSE: MINDTREE | BSE: 53...
    Tata Elxsi Ltd. NSE: TATAELXSI | BSE:...
    Coforge Ltd. NSE: COFORGE | BSE: 5325...
    Hexaware Technologies Ltd. NSE: HEXAW...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020